Zealand Pharma Drug Patent Portfolio
Zealand Pharma owns 2 orange book drugs protected by 2 US patents Given below is the list of Zealand Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10442847 | Glucagon analogues | 03 Feb, 2035 | Active |
| US11795204 | Glucagon analogues | 06 Jan, 2034 | Active |
Latest Legal Activities on Zealand Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zealand Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail Patent eCofC Notification | 25 Jun, 2024 | US11795204 |
| Recordation of Patent eCertificate of Correction | 25 Jun, 2024 | US11795204 |
| Patent eCofC Notification | 25 Jun, 2024 | US11795204 |
|
Email Notification
Critical
| 25 Jun, 2024 | US11795204 |
| Mail Patent eCofC Notification | 25 Jun, 2024 | US11795204 |
|
Email Notification
Critical
| 25 Jun, 2024 | US11795204 |
| Recordation of Patent eCertificate of Correction | 25 Jun, 2024 | US11795204 |
| Patent eCofC Notification | 25 Jun, 2024 | US11795204 |
| Post Issue Communication - Certificate of Correction | 05 Jun, 2024 | US11795204 |
| Post Issue Communication - Certificate of Correction | 05 Jun, 2024 | US11795204 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US10442847 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US10442847 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Oct, 2023 | US11795204 |
|
Email Notification
Critical
| 24 Oct, 2023 | US11795204 |
| Recordation of Patent eGrant | 24 Oct, 2023 | US11795204 |
Zealand Pharma's Family Patents
Zealand Pharma Drug List
Given below is the complete list of Zealand Pharma's drugs and the patents protecting them.
1. Zegalogue
Zegalogue is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10442847 | Glucagon analogues |
03 Feb, 2035
(9 years from now)
| Active |
| US11795204 | Glucagon analogues |
06 Jan, 2034
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegalogue's drug page
2. Zegalogue (autoinjector)
Zegalogue (autoinjector) is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10442847 | Glucagon analogues |
03 Feb, 2035
(9 years from now)
| Active |
| US11795204 | Glucagon analogues |
06 Jan, 2034
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegalogue (autoinjector)'s drug page